NCT01137851已完成不适用
Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients Treated With Biologic Disease Modifying Antirheumatic Drug (DMARD) Therapies
Bristol-Myers Squibb0 个研究点目标入组 3,940 人开始时间: 2009年11月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,940
- 主要终点
- Effect of patient cost share on discontinuation
研究概览
简要总结
The purpose of this study is to assess the impact of patient cost sharing on treatment discontinuation of biologic agents in patients with Rheumatoid Arthritis (RA)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 to 64 years of age at index date
- •Diagnosis of RA during the study period (ICD-9CM 714.xx)
- •Evidence of at least one biologic DMARD of interest during the study timeframe
- •Continuous enrollment during the study timeframe
- •Both medical and pharmacy benefits
- •No evidence of a claim for a bDMARD in the 6-month pre-period
排除标准
- •Patients are excluded if they have a diagnosis of psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, or ulcerative colitis at any time during the study timeframe; have a claim for Rituxan, IV etanercept, or IV adalimumab; or have Medicare or Medicaid during the study timeframe
结局指标
主要结局
Effect of patient cost share on discontinuation
时间窗: Assessed from first prescription date and followed for 1-year
次要结局
- RA-related healthcare utilization and costs(Post-period: Index date+365 days)
- All-cause healthcare utilization and costs(Post-period: Index date+365 days)
研究者
相似试验
已完成
不适用
The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy UseDepressive Disorder, MajorNCT01141400Otsuka Pharmaceutical Development & Commercialization, Inc.48,865
已完成
不适用
Cost and Shared Decision-Making for Heart FailureChronic Heart FailureNCT04793880Emory University247
已完成
2 期
Study to Improve Partner Services for STD PreventionTrichomonas VaginalisUrethritisNCT00207467Centers for Disease Control and Prevention1,500
尚未招募
不适用
Cost Analysis of Therapies for Severe AnemiaSevere AnemiaNCT06345469Helios Klinik Gotha/Ohrdruf640
撤回
不适用
Metastatic Breast Cancer Treatment PlanningMetastatic Breast CancerNCT03127332Carevive Systems, Inc.